ArticlePharmaceuticals (Basel, Switzerland)2022

Real-World Comparative Evaluation of Add-On Glucagon-like Peptide 1 Receptor Agonist in Type 2 Diabetes Treated with or without Insulin.

Hsuan-Wen Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.